TCL Archive A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion. June 4, 2004
TCL Archive Wyden Asks Bristol For documentation To Prove That Taxol Price Is Not “Gouging” Taxpayers January 29, 1993
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006
